Company Filing History:
Years Active: 2025
Title: Jordan R Willis: Innovator in Engineered Polypeptides
Introduction
Jordan R Willis is a notable inventor based in Hayward, CA (US). He has made significant contributions to the field of biotechnology, particularly in the development of engineered polypeptides. His work focuses on innovative solutions that enhance the selection and application of binding molecules.
Latest Patents
Jordan R Willis holds a patent for "Engineered CD25 polypeptides and uses thereof." This patent provides engineered polypeptides that incorporate a combination of spatially-associated topological constraints. At least one of these constraints is derived from a CD25 reference target. The patent also outlines methods for selecting these engineered polypeptides and their applications, including their use as positive and/or negative selection molecules in screening libraries of binding molecules such as antibodies. Additionally, the patent details CD25 antibodies selected using these engineered polypeptides.
Career Highlights
Jordan R Willis is currently associated with Ibio Limited, where he continues to advance his research and development efforts. His innovative approach has positioned him as a key player in the biotechnology sector.
Collaborations
Some of his notable coworkers include Matthew Paul Greving and Phung Tu Gip. Their collaborative efforts contribute to the ongoing success and innovation within their field.
Conclusion
Jordan R Willis exemplifies the spirit of innovation in biotechnology through his work on engineered polypeptides. His contributions are paving the way for advancements in the selection and application of binding molecules.